StockWatch
·

Apex Frozen Foods Ltd Q1 FY27 Results

APEXQ1 FY27 Results
Filing
Result:Good· Market: SurgedMargin expansionBase effectCost led
MetricValueChangeQ1 FY26
Revenue256.53 Cr0.6%
Total Income259.31 Cr0.7%
Expenditure230.72 Cr7.0%
PBT28.59 Cr120.7%
Net Profit21.67 Cr138.1%
OPM11.79%5.80pp
NPM8.35%4.87pp
EPS6.93138.1%
View full financials

Revenue was flat YoY but PAT more than doubled on sharp margin expansion (OPM 6.0%→11.8%), a lower-base-driven cost/margin story rather than core volume growth.

Q1 FY-2027 RESULTS · APEX

PAT jumps 138% YoY to ₹21.7 Cr, but inventory build drives gain as revenue stays flat

PAT +138.12% YoY · revenue -0.63% · margins expanding

13 Aug 2026 · 3 min read
Revenue

₹256.53 Cr

-0.63% YoY

PAT (standalone)

₹21.67 Cr

+138.12% YoY

Net margin

8.36%

+4.9pp YoY

EPS

₹6.93

Apex Frozen Foods reported standalone net profit of ₹21.67 Cr for Q1 FY27 (quarter ended June 30, 2026), up 138% YoY (₹9.10 Cr) and 178% QoQ (₹7.79 Cr), with EPS of ₹6.93 against ₹2.91 a year ago. Revenue from operations was essentially flat YoY at ₹256.53 Cr (-0.6%) versus ₹258.16 Cr in Q1 FY26, though it jumped 52.9% QoQ off a seasonally weak Q4 FY26 base of ₹167.82 Cr. On the surface this reads as a sharp margin-expansion quarter: net profit margin rose to 8.45% from 3.52% YoY (4.64% QoQ), and EBITDA margin (PBT + finance cost + depreciation, over revenue) improved to roughly 12.9% from ~7.1% YoY — nominally above management's own target of sustaining ~7% EBITDA margin with 10% upside, flagged on the February 2026 concall.

The scoreboard

Q1 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹256.53 Cr-0.6%
Expenses₹230.72 Cr-7%
PAT₹21.67 Cr+178.24%+138.12%
Net margin8.36%+4.9pp
EPS₹6.93+138.1%

That headline needs a caveat. Roughly ₹18.83 Cr of the YoY increase in profit before tax traces to the 'changes in inventories of finished goods & biological assets' line, which credited ₹28.51 Cr to the P&L this quarter versus a ₹9.68 Cr credit a year ago — a larger build-up of unsold shrimp inventory flattered reported costs. That swing alone exceeds the entire ₹15.63 Cr YoY increase in PBT (₹28.59 Cr vs ₹12.95 Cr). Normalising for it (holding the inventory-change benefit at last year's level, same effective tax rate), PBT would have been about ₹9.76 Cr versus ₹12.95 Cr a year ago (down ~25%), and PAT roughly ₹7.40 Cr versus ₹9.10 Cr (down ~19%) — a decline rather than a jump. A lower effective tax rate (24.2% vs 29.8% YoY) also padded the reported PAT gain. No exceptional items were disclosed in any period, so this is a working-capital/inventory-valuation effect, not a one-off write-back — but it means headline profit growth overstates the underlying operating improvement, and whether it holds up depends on that inventory converting to sales in Q2 FY27.

351.64391.18430.73470.27509.81367.705-1106-0306-2507-2008-1108-13Q1 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹367.7, down 9.9% over the past month of trading.

₹ Cr
-2.856.215.2524.29-0.22Q3 FY25rev ₹231 Cr1.96Q4 FY25rev ₹197 Cr9.1Q1 FY26rev ₹258 Cr11.87Q2 FY26rev ₹238 Cr10.09Q3 FY26rev ₹264 Cr21.67Q1 FY27rev ₹257 Cr
Quarterly standalone PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records.

What management guided (3 FY-2026 call)
Management projects significant revenue growth to over INR 1,200 crores in the next two years, driven by recovering US volumes after tariff reductions and new opportunities from the India-EU FTA. They expect to sustain current EBITDA margins of approximately 7%, with potential upside towards 10% fueled by operating lev

This quarter: met

On guidance: management's February 2026 outlook called for revenue to grow to over ₹1,200 Cr within two years (aided by recovering US volumes post-tariff cuts and the India-EU FTA) while sustaining ~7% EBITDA margins with upside to 10%, and targeted 50% capacity utilisation by FY27. This quarter's flat YoY revenue (annualised run-rate ~₹1,026 Cr) shows no progress yet on the growth leg, even as the margin metric nominally screens ahead of target — though, as above, that figure is inventory-swing-assisted. No formal Street consensus for this specific quarter was found; broader analyst commentary points to a full-year FY27 PAT growth expectation of 15-20% (over FY26's ₹38.85 Cr) and management's own internal volume target of ~30% YoY, conditioned on stable trade/logistics — against which this quarter's flat value-terms revenue is not yet showing that growth. The company reiterated it has no subsidiaries, associates or JVs, so no consolidated statement was filed (Note 3). There were no other quarter-specific corporate developments (deals, capex, management changes) tied to these numbers; the FY26 final dividend of ₹2.50/share recommended on May 30, 2026 relates to the prior year, not this quarter.

  • W1

    Whether the ₹28.51 Cr finished-goods/biological-asset inventory build converts to sales in Q2 FY27 — non-conversion would reverse this quarter's margin/profit boost

  • W2

    Revenue trajectory versus management's >₹1,200 Cr two-year target and FY27 50% capacity-utilisation goal, given this quarter's flat YoY print

  • W3

    Sustainability of the ~12.9% EBITDA margin against management's 7% (10% upside) target band once the inventory-swing effect normalises

Informational and educational content only. Not investment advice.

Apex Frozen Foods Ltd (APEX) Q1 FY27 Results — StockWatch